Josep Rodés-Cabau1, Marina Urena2, Luis Nombela-Franco3, Ignacio Amat-Santos4, Neal Kleiman5, Antonio Munoz-Garcia6, Felipe Atienza7, Vicenç Serra8, Marc W Deyell9, Gabriela Veiga-Fernandez10, Jean-Bernard Masson11, Victoria Canadas-Godoy3, Dominique Himbert2, Javier Castrodeza4, Jaime Elizaga7, Jaume Francisco Pascual8, John G Webb9, Jose Maria de la Torre10, Lluis Asmarats12, Emilie Pelletier-Beaumont12, François Philippon12. 1. Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada. Electronic address: josep.rodes@criucpq.ulaval.ca. 2. Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Höpital Bichat-Claude Bernard, Paris, France. 3. Instituto Cardiovascular, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. 4. Department of Cardiology, Hospital Universitario de Valladolid, Valladolid, Spain. 5. Department of Cardiology, Hospital Virgen de la Victoria, Málaga, Spain. 6. Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. 7. Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 8. Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 9. Department of Cardiology, St Paul's Hospital, Vancouver, British Columbia, Canada. 10. Department of Cardiology, Hospital Marques de Valdecilla, Santander, Spain. 11. Department of Cardiology, Centre Hospitalier Universitaire de Montreal, Montreal, Quebec, Canada. 12. Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Abstract
OBJECTIVES: The authors sought to determine: 1) the global arrhythmic burden; 2) the rate of arrhythmias leading to a treatment change; and 3) the incidence of high-degree atrioventricular block (HAVB) at 12-month follow-up in patients with new-onset persistent left bundle branch block (LBBB) following transcatheter aortic valve replacement (TAVR). BACKGROUND: Controversial data exist on the occurrence of significant arrhythmias in patients with LBBB post-TAVR. METHODS: This was a multicenter prospective study including 103 consecutive patients with new-onset persistent LBBB post-TAVR with the balloon-expandable SAPIEN XT/3 valve (n = 53), or the self-expanding CoreValve/Evolut R system (n = 50). An implantable cardiac monitor (Reveal XT, Reveal Linq) was implanted at 4 (3 to 6) days post-TAVR, and patients had continuous electrocardiogram monitoring for 12 months. All arrhythmic events were adjudicated in a central electrocardiography core lab. Primary endpoints were the incidence of arrhythmias leading to a treatment change, and the incidence of HAVB at 12-month follow-up. RESULTS: A total of 1,553 new arrhythmic events were detected in 44 patients (1,443 episodes of tachyarrhythmia in 26 patients [atrial fibrillation/flutter/atrial tachycardia: 1,427, ventricular tachycardia 16]; 110 episodes of bradyarrhythmia in 21 patients [HAVB 54, severe bradycardia 56]). All arrhythmic events were silent in 34 patients (77%), the arrhythmic event led to a treatment change in 19 patients (18%), and 11 patients (11%) required pacemaker or implantable cardioverter-defibrillator implantation (due to HAVB, severe bradycardia, or ventricular tachycardia episodes in 9, 1, and 1 patient, respectively). A total of 12 patients died at 1-year follow-up, 1 from sudden death. CONCLUSIONS: A high incidence of arrhythmic events was observed at 1-year follow-up in close to one-half of the patients with LBBB post-TAVR. Significant bradyarrhythmias occurred in one-fifth of the patients, and PPM was required in nearly one-half of them. These data support the use of a cardiac monitoring device for close follow-up and expediting the initiation of treatment in this challenging group of patients. (Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation [MARE study]: NCT02153307).
OBJECTIVES: The authors sought to determine: 1) the global arrhythmic burden; 2) the rate of arrhythmias leading to a treatment change; and 3) the incidence of high-degree atrioventricular block (HAVB) at 12-month follow-up in patients with new-onset persistent left bundle branch block (LBBB) following transcatheter aortic valve replacement (TAVR). BACKGROUND: Controversial data exist on the occurrence of significant arrhythmias in patients with LBBB post-TAVR. METHODS: This was a multicenter prospective study including 103 consecutive patients with new-onset persistent LBBB post-TAVR with the balloon-expandable SAPIEN XT/3 valve (n = 53), or the self-expanding CoreValve/Evolut R system (n = 50). An implantable cardiac monitor (Reveal XT, Reveal Linq) was implanted at 4 (3 to 6) days post-TAVR, and patients had continuous electrocardiogram monitoring for 12 months. All arrhythmic events were adjudicated in a central electrocardiography core lab. Primary endpoints were the incidence of arrhythmias leading to a treatment change, and the incidence of HAVB at 12-month follow-up. RESULTS: A total of 1,553 new arrhythmic events were detected in 44 patients (1,443 episodes of tachyarrhythmia in 26 patients [atrial fibrillation/flutter/atrial tachycardia: 1,427, ventricular tachycardia 16]; 110 episodes of bradyarrhythmia in 21 patients [HAVB 54, severe bradycardia 56]). All arrhythmic events were silent in 34 patients (77%), the arrhythmic event led to a treatment change in 19 patients (18%), and 11 patients (11%) required pacemaker or implantable cardioverter-defibrillator implantation (due to HAVB, severe bradycardia, or ventricular tachycardia episodes in 9, 1, and 1 patient, respectively). A total of 12 patients died at 1-year follow-up, 1 from sudden death. CONCLUSIONS: A high incidence of arrhythmic events was observed at 1-year follow-up in close to one-half of the patients with LBBB post-TAVR. Significant bradyarrhythmias occurred in one-fifth of the patients, and PPM was required in nearly one-half of them. These data support the use of a cardiac monitoring device for close follow-up and expediting the initiation of treatment in this challenging group of patients. (Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation [MARE study]: NCT02153307).
Authors: Mohanad Hamandi; Deborah Tabachnick; Allison T Lanfear; Ronald Baxter; Kathryn Shin; Brittany Zingler; Michael J Mack; J Michael DiMaio; Steven Kindsvater Journal: Proc (Bayl Univ Med Cent) Date: 2020-01-30
Authors: Christopher U Meduri; Dean J Kereiakes; Vivek Rajagopal; Raj R Makkar; Daniel O'Hair; Axel Linke; Ron Waksman; Vasilis Babliaros; Robert C Stoler; Gregory J Mishkel; David G Rizik; Vijay S Iyer; John Schindler; Dominic J Allocco; Ian T Meredith; Ted E Feldman; Michael J Reardon Journal: J Am Heart Assoc Date: 2019-10-23 Impact factor: 5.501
Authors: Korbinian Lackermair; Stephanie Fichtner; Bonnie Hartrampf; David Jochheim; Julius Steffen; Thomas Czermak; Sebastian Sadoni; Erik Lemmermöhle; Ina Klier; Heidi L Estner; Steffen Massberg; Julinda Mehilli Journal: Sci Rep Date: 2021-12-21 Impact factor: 4.379
Authors: Pablo M Ruiz-Hernandez; Esteban Gonzalez-Torrecilla; Enrique Gutierrez-Ibañez; Hugo Gonzalez-Saldivar; Vanesa Bruña; Gerard Loughlin; Evaristo Castellanos; Pablo Avila; Felipe Atienza; Tomas Datino; Jaime Elizaga; Angel Arenal; Francisco Fernández-Aviles Journal: Int J Cardiol Heart Vasc Date: 2020-11-01